Shanzhiside methylesterCAS# 64421-28-9 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 64421-28-9 | SDF | Download SDF |
PubChem ID | 3085296 | Appearance | White powder |
Formula | C17H26O11 | M.Wt | 406.4 |
Type of Compound | Iridoids | Storage | Desiccate at -20°C |
Solubility | Soluble in methan | ||
Chemical Name | methyl (1S,5R,7S)-5,7-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylate | ||
SMILES | CC1(CC(C2C1C(OC=C2C(=O)OC)OC3C(C(C(C(O3)CO)O)O)O)O)O | ||
Standard InChIKey | KKSYAZCUYVRKML-QDXNKOLPSA-N | ||
Standard InChI | InChI=1S/C17H26O11/c1-17(24)3-7(19)9-6(14(23)25-2)5-26-15(10(9)17)28-16-13(22)12(21)11(20)8(4-18)27-16/h5,7-13,15-16,18-22,24H,3-4H2,1-2H3/t7-,8-,9?,10?,11-,12+,13-,15+,16+,17+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Shanzhiside methylester reduces neuropathic pain by activating spinal GLP-1 receptors and subsequently stimulating microglial β-endorphin expression via the p38 MAPK signaling. |
Targets | p38MAPK | GLP-1 receptor |
In vivo | Shanzhiside methylester, the principle effective iridoid glycoside from the analgesic herb Lamiophlomis rotata, reduces neuropathic pain by stimulating spinal microglial β-endorphin expression.[Pubmed: 26363192 ]Neuropharmacology. 2016 Feb;101:98-109Lamiophlomis rotata (L. rotata, Duyiwei) is an orally available Tibetan analgesic herb widely prescribed in China. Shanzhiside methylester (SM) is a principle effective iridoid glycoside of L. rotata and serves as a small molecule glucagon-like peptide-1 (GLP-1) receptor agonist. This study aims to evaluate the signal mechanisms underlying SM anti-allodynia, determine the ability of SM to induce anti-allodynic tolerance, and illustrate the interactions between SM and morphine, or SM and β-endorphin, in anti-allodynia and anti-allodynic tolerance.
|
Structure Identification | Biomed Chromatogr. 2012 Dec;26(12):1543-51.Simultaneous determination of four shanzhiside methylester derivatives in rabbit plasma by liquid chromatography/tandem mass spectrometry.[Pubmed: 22422345]
|
Shanzhiside methylester Dilution Calculator
Shanzhiside methylester Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.4606 mL | 12.3031 mL | 24.6063 mL | 49.2126 mL | 61.5157 mL |
5 mM | 0.4921 mL | 2.4606 mL | 4.9213 mL | 9.8425 mL | 12.3031 mL |
10 mM | 0.2461 mL | 1.2303 mL | 2.4606 mL | 4.9213 mL | 6.1516 mL |
50 mM | 0.0492 mL | 0.2461 mL | 0.4921 mL | 0.9843 mL | 1.2303 mL |
100 mM | 0.0246 mL | 0.123 mL | 0.2461 mL | 0.4921 mL | 0.6152 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Mussaenoside
Catalog No.:BCN4186
CAS No.:64421-27-8
- DL-2-Amino-n-octanoic acid
Catalog No.:BCC8949
CAS No.:644-90-6
- Precocene II
Catalog No.:BCN4605
CAS No.:644-06-4
- Alloalantolactone
Catalog No.:BCN8091
CAS No.:64340-41-6
- N6-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyadenosine
Catalog No.:BCC9074
CAS No.:64325-78-6
- Malvidin chloride
Catalog No.:BCN3017
CAS No.:643-84-5
- Dracorhodin
Catalog No.:BCC9226
CAS No.:643-56-1
- Galactopinitol A
Catalog No.:BCC8926
CAS No.:64290-91-1
- Acetagastrodin
Catalog No.:BCN8155
CAS No.:64291-41-4
- Tetrahydropapaverine HCl
Catalog No.:BCC5321
CAS No.:6429-04-5
- Kielcorin
Catalog No.:BCN7637
CAS No.:64280-48-4
- Boc-N-Me-Tyr(Bzl)-OH
Catalog No.:BCC3356
CAS No.:64263-81-6
- Grifolin monomethyl ether
Catalog No.:BCN7568
CAS No.:64432-04-8
- Dulcoside A
Catalog No.:BCN3237
CAS No.:64432-06-0
- 10-Hydroxycamptothecin
Catalog No.:BCN1226
CAS No.:64439-81-2
- Tizanidine HCl
Catalog No.:BCC4357
CAS No.:64461-82-1
- Picroside III
Catalog No.:BCN6324
CAS No.:64461-95-6
- Glycoursodeoxycholic acid
Catalog No.:BCN7369
CAS No.:64480-66-6
- Cefotaxime sodium
Catalog No.:BCC8908
CAS No.:64485-93-4
- Rubianthraquinone
Catalog No.:BCN6880
CAS No.:644967-44-2
- Altretamine
Catalog No.:BCC1216
CAS No.:645-05-6
- Isovanillic acid
Catalog No.:BCN3376
CAS No.:645-08-9
- Scoulerine
Catalog No.:BCN6623
CAS No.:6451-73-6
- Oxprenolol hydrochloride
Catalog No.:BCC7630
CAS No.:6452-73-9
Simultaneous determination of four shanzhiside methylester derivatives in rabbit plasma by liquid chromatography/tandem mass spectrometry.[Pubmed:22422345]
Biomed Chromatogr. 2012 Dec;26(12):1543-51.
A simple and sensitive high-performance liquid chromatography/tandem mass spectrometry (LC/MS/MS) method was developed and validated for simultaneous determination of Shanzhiside methylester and its three derivatives in rabbit plasma. The method showed good linearity and no endogenous material interfered with the marked compounds and internal standard (IS) capatol peaks. Samples were processed by acetonitrile precipitation. Chromatography was performed using a C(1)(8) column (150 x 3.9 mm i.d., 4 microm). The mobile phase consisted of methanol and water (60:40, v/v) during a total run time of 7 min. The main mass parent ions and daughter ions pairs (m/z) for monitoring were: Shanzhiside methylester, 429.0/267.4; 8-O-acetyl Shanzhiside methylester, 470.9/411.3; loganin, 413.2/251.4; phloyoside II, 479.2/281.3; and IS 385.2/203.3. Finally, the method was applied to a pharmacokinetic study of rabbits following intravenous administration of iridoid glycosides extracted from traditional herb Lamiophlomis rotata.
Shanzhiside methylester, the principle effective iridoid glycoside from the analgesic herb Lamiophlomis rotata, reduces neuropathic pain by stimulating spinal microglial beta-endorphin expression.[Pubmed:26363192]
Neuropharmacology. 2016 Feb;101:98-109.
Lamiophlomis rotata (L. rotata, Duyiwei) is an orally available Tibetan analgesic herb widely prescribed in China. Shanzhiside methylester (SM) is a principle effective iridoid glycoside of L. rotata and serves as a small molecule glucagon-like peptide-1 (GLP-1) receptor agonist. This study aims to evaluate the signal mechanisms underlying SM anti-allodynia, determine the ability of SM to induce anti-allodynic tolerance, and illustrate the interactions between SM and morphine, or SM and beta-endorphin, in anti-allodynia and anti-allodynic tolerance. Intrathecal SM exerted dose-dependent and long-lasting (>4 h) anti-allodynic effects in spinal nerve injury-induced neuropathic rats, with a maximal inhibition of 49% and a projected ED50 of 40.4 mug. SM and the peptidic GLP-1 receptor agonist exenatide treatments over 7 days did not induce self-tolerance to anti-allodynia or cross-tolerance to morphine or beta-endorphin. In contrast, morphine and beta-endorphin induced self-tolerance and cross-tolerance to SM and exenatide. In the spinal dorsal horn and primary microglia, SM significantly evoked beta-endorphin expression, which was completely prevented by the microglial inhibitor minocycline and p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580. SM anti-allodynia was totally inhibited by the GLP-1 receptor antagonist exendin(9-39), minocycline, beta-endorphin antiserum, mu-opioid receptor antagonist CTAP, and SB203580. SM and exenatide specifically activated spinal p38 MAPK phosphorylation. These results indicate that SM reduces neuropathic pain by activating spinal GLP-1 receptors and subsequently stimulating microglial beta-endorphin expression via the p38 MAPK signaling. Stimulation of the endogenous beta-endorphin expression may be a novel and effective strategy for the discovery and development of analgesics for the long-term treatment of chronic pain.